Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIBRA: Vaginal prasterone for vaginal atrophy in breast cancer patients on aromatase inhibitors
2020-001077-79Phase 4Completed
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Jun 2020
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dehydroepiandrosterone in vaginal atrophy, sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Ultrasensitive estradiol plasma levels. Started Jun 2020; status: completed.
02
Drugs
dehydroepiandrosterone
03
Conditions
vaginal atrophy
Beyond the preview
Go deeper on 2020-001077-79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001077-79.